Risk Factors for Community-Acquired Ciprofloxacin-Resistant <i>Escherichia Coli</i> Urinary Tract Infection

Abstract

Fluoroquinolones continue to be appropriate empiric treatment in most patients with uncomplicated UTI. Nitrofurantoin or a cephalosporin may be better choices in patients with recurrent lower UTI and/or previous fluoroquinolone use.